Eden Miller, DO, shares key takeaways on how personalized treatment helps in the management of diabetes.
The new app is designed to help persons with diabetes understand how food and activity impact blood glucose levels and to revise behavior accordingly.
COVID-19 has dealt in-person addiction treatment a blow, but the chief medical officer of Groups Recover Together tells a telemedicine success story with a hybrid ending.
Train your staff well, says this expert in business texting solutions, and make sure to develop and use appropriate checks and balances.
Neil Skolnik, MD, reviews the currently available vaccine technologies, highlighting their mechanisms of action and individual delivery methods.
A recent American Kidney Fund survey of 300 primary care and specialty clinicians found ~15% of their patients had kidney disease of unknown origin.
Benjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.
Investigators identified 6 blood pressure patterns that, when combined with other risk factors, accurately stratified risk of hypertensive disorders of pregnancy.
Beginning on Sept 24, 2024, all women must be notified of their breast density status in mammography reports and encouraged to pursue supplemental screening.
FDA's action, based on confirmatory evidence showing slowed disease progression, follows a January 2023 accelerated approval.
Peer mentor programs can provide support for patients, especially when it comes to family planning and parenthood.
How current are you on CAC and its place in CVD risk assessment? This short quiz will reveal your score.
Well-known ID specialist Bill Schaffner, MD, and active primary care educator Chuck Vega, MD, offer thoughts on how to get shots into arms in the 2023-2024 respiratory virus season.
WHO: Evidence is lacking for clinical effectiveness of Xevudy and Regen-Cov against the COVID-19 variants that are currently circulating.
Obesity requires a spectrum of treatment options for effective results. Here, 3 key points to keep in mind when considering antiobesity medication for patients.
Research shows that increased risk of chronic disease and mortality begins below a BMI classified as obesity. The earlier we intervene with at-risk patients, the greater the chance for success.
Roger S. McIntyre, MD, FRCPC, discusses the history of psychiatry and the conventional treatment and response times, leading into the current treatment armamentarium for treatment of major depressive disorder (MDD).
Mental wellbeing for some persons with chronic pain appears to be associated with the flexibility to adjust goals and persevere despite obstacles, setbacks, note study authors.
Hyperbaric oxygen therapy in a randomized placebo-controlled trial resulted in improved global cognitive function, energy, sleep, and pain interference in long COVID patients.
“Patients with COPD who have AMI are less aggressively treated than those without COPD," leading to higher in-hospital mortality and long-term mortality,” wrote authors.
An overview of common and uncommon obesity-related comorbidities and treatment strategies, here.
Three tips on how to support patients on their weight management journey this year.
Understanding the interplay between obesity and depression in children is key for clinicians to best advise this patient population. An overview, here.
Atrial fibrillation prevalence is rising across socioeconomic strata globally, the new analysis finds, with effects of BMI, ETOH, and sedentary behavior shifting as key drivers.
2 Clarke Drive Cranbury, NJ 08512